Does PEMBROLIZUMAB Cause Liver disorder? 498 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 498 reports of Liver disorder have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.6% of all adverse event reports for PEMBROLIZUMAB.
498
Reports of Liver disorder with PEMBROLIZUMAB
0.6%
of all PEMBROLIZUMAB reports
93
Deaths
287
Hospitalizations
How Dangerous Is Liver disorder From PEMBROLIZUMAB?
Of the 498 reports, 93 (18.7%) resulted in death, 287 (57.6%) required hospitalization, and 42 (8.4%) were considered life-threatening.
Is Liver disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 498 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Liver disorder?
METHOTREXATE (3,119)
ADALIMUMAB (2,502)
ETANERCEPT (1,990)
TOCILIZUMAB (1,853)
ABATACEPT (1,759)
RITUXIMAB (1,736)
ACETAMINOPHEN (1,723)
LEFLUNOMIDE (1,599)
TOFACITINIB (1,584)
HYDROXYCHLOROQUINE (1,514)
Which PEMBROLIZUMAB Alternatives Have Lower Liver disorder Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G